Great!
"...
- This study showed that 64Cu-SAR-bisPSMA is effective in detecting lesions in PC patients with BCR, who had a negative or equivocal SOC scan at study entry.
- More lesions and more participants with a positive scan were identified earlier by 64Cu-SAR-bisPSMA vs. SOC PSMA imaging.
- Results indicate that 64Cu-SAR-bisPSMA is able to identify lesions from 29 days to more than 6 months earlier than SOC PSMA agents.
- Lesions <5 mm in diameter were identified by 64Cu-SAR-bisPSMA in 14% of participants.
These findings have important clinical implications as the early identification of lesions in BCR patients can inform different treatment pathways.
..."
- Forums
- ASX - By Stock
- Ann: Clarity to present COBRA and CLARIFY abstracts
CU6
clarity pharmaceuticals ltd
Add to My Watchlist
4.64%
!
$4.11

Great!"...This study showed that 64Cu-SAR-bisPSMA is effective...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$4.11 |
Change
-0.200(4.64%) |
Mkt cap ! $1.329B |
Open | High | Low | Value | Volume |
$4.20 | $4.27 | $4.09 | $7.447M | 1.792M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 1000 | $4.11 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$4.12 | 2000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 4000 | 4.100 |
2 | 498 | 4.090 |
4 | 20302 | 4.080 |
5 | 10307 | 4.050 |
1 | 1000 | 4.040 |
Price($) | Vol. | No. |
---|---|---|
4.120 | 2000 | 1 |
4.170 | 1699 | 1 |
4.190 | 6000 | 1 |
4.200 | 7776 | 2 |
4.210 | 5000 | 1 |
Last trade - 16.10pm 25/07/2025 (20 minute delay) ? |
Featured News
CU6 (ASX) Chart |
The Watchlist
P.HOTC
HotCopper
Frazer Bourchier, Director, President and CEO
Frazer Bourchier
Director, President and CEO
SPONSORED BY The Market Online